Phase I/II trial of Recombinant Asparaginase in adults patients with relapsed/refractory haematological neoplasias

Trial Profile

Phase I/II trial of Recombinant Asparaginase in adults patients with relapsed/refractory haematological neoplasias

Completed
Phase of Trial: Phase I/II

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Asparaginase (Primary)
  • Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Non-Hodgkin's lymphoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top